
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM
("CPH2", the "Company" or the "Group")
Result of General Meeting and Total Voting Rights
CPH2, the
Capitalised terms used in this announcement (the "Announcement") have the meanings given to them in the Launch Announcement, unless the context provides otherwise.
All resolutions set out in the Notice of General Meeting were passed by the requisite majority. The results of the poll for each resolution will be available shortly on the Company's website at: www.cph2.com.
Admission and Total Voting Rights
Applications have been made to the London Stock Exchange for each admission of the New Shares to trading on AIM and it is expected that:
· admission of the EIS/VCT Shares will take place at
· admission of the Non-EIS/VCT Shares will take place at
Following Second Admission, the Company will have 502,013,083 Ordinary Shares in issue with the Company holding no Ordinary Shares in treasury. Therefore, the total number of voting rights will also be 502,013,083. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information, please contact:
|
via Camarco |
|
|
|
|
|
|
|
|
Cavendish |
|
|
+44 (0)131 220 9771 |
|
+44 (0)131 220 9772 |
|
+44 (0)131 220 9778 |
|
|
|
|
Camarco PR |
+44 (0)20 3757 4980 |
|
|
|
|
Further information on the Company can be found on its website at: https://www.cph2.com/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the